본문 바로가기
  • Home

A Comparative Review on Carthmi-Flos Pharmacopuncture Treatment - Focused on Clinical Study

  • Journal of Korean Medicine Rehabilitation
  • Abbr : JKMR
  • 2017, 27(4), pp.55-65
  • Publisher : The Korean Academy Of Oriental Rehabilitation Medicine
  • Research Area : Medicine and Pharmacy > Korean Medicine

Soo-Hwan Lee 1 윤정원 1 Kim, Soon-joong 1

1세명대학교

Accredited

ABSTRACT

ObjectivesThe purpose of this review is to analyze results of case studies and controlled studies about Carthmi-Flos pharmacopuncture. Based on the review, authors desire to suggest the study model including precise information and evident the effect of Carthmi-Flos pharmacopuncture objectively in treating clinical disorders.MethodsWe search 44 studies about Carthmi-Flos pharmacopuncture from 6 Korean web databases, using words ‘Carthmi-Flos pharmacopuncture’ in Korean alphabet. This study had been conducted throughout 1 month (July, 2017). We selected case studies and controlled trials in investigated 44 thesis, excluding experimental research and thesis not using the Carthmi-Flos pharmacopuncture for major treatment.ResultsWe analyze 13 case reports and 7 controlled trials. As a result, Carthmi-Flos Pharmacopuncture was used mostly in musculoskeletal, neurological diseases. But this can be applied to internal diseases. Disorders reported effectively were carpal tunnel syn-drome, degenerative knee joint arthritis, posterior neck pain, low back pain, radial nerve palsy, shoulder pain, lumbar compression fracture, alopecia areata, chronic daily head-ache, duverney fracture, oligomenorrhea, cervical disc herniation, rheumatoid arthritis and cervical headache.ConclusionsAs we analyzed, Carthmi-Flos pharmacopuncture is specifically effective in musculoskeletal and neurologic diseases. But there are various problems in study design. To design accurately, the study design should include much more specific information. And the result can be more precise by excluding other methods. (J Korean Med Rehabil 2017;27(4):55-65)

Citation status

* References for papers published after 2023 are currently being built.